Regional Blood Flow Clinical Trial
Official title:
Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People
With age, muscles tend to waste at 0.5-1% per year, so that an 80 year old may have only 70% of the muscle possessed at 50. Muscle loss makes it harder to carry out tasks that require strength, keep the body balanced and continue activity for a prolonged period, which together may contribute to a loss of independence and an increased risk of falls. The cause of some of this muscle loss with ageing appears to be a reduction in muscle building in response to food. The known decreased limb blood flow in ageing muscle may go some way to explain this as there may be less nutrient delivery to the muscles. The investigators want to test if the known decrease in limb blood flow with age is matched with a decrease in the proportion of blood being delivered directly to the muscles, rather than fat and connective tissue. If so the investigators expect to see an improvement in the ability of muscles to maintain themselves via better capture of amino acids into protein. The investigators also want to test if 20 weeks resistance exercise training or drinking a cocktail of mixture of high flavanol cocoa (which can increase blood flow) and vitamin C can improve limb blood flow to older muscles and help reduce muscle wasting.
By 2020, 20% of the UK population will be over 65 y. Muscle mass is a strong predictor of
healthy ageing and longevity. Basal limb blood flow decreases with advancing age; reduced
limb perfusion may contribute to sarcopenia, the undesirable loss of muscle mass that
accompanies advancing age. The investigators previous work has shown that there are deficits
in the mechanisms of muscle protein synthesis in older people, but why these exist and how
they may be countered is still unknown. After normal feeding, increased amino acid
availability (stimulating muscle protein synthesis) and insulin availability (inhibiting
muscle protein breakdown) do have good effects in the muscle of older people but not to the
same extent as in the young; the investigators call this "anabolic resistance". The
investigators have recently shown that leg blood flow in elderly people is lower than in the
young at rest in the basal state and also at rest up to 2.5 hours after food and or food +
exercise. The matching of blood flow and metabolism is advantageous for skeletal muscle, in
marrying demands for oxygen and nutrients to their delivery; the reduced limb perfusion in
the older people may contribute to an inability to maintain muscle mass with ageing. The
investigators have recently shown that resistance training markedly improves leg blood flow
responses in elderly persons. They believe a major benefit of resistance exercise is to
increase endothelium dependent vasodilation in response to feeding and moderate exercise,
but this needs to be proved. It is becoming recognised that it is not only "bulk" limb blood
flow that may be important in muscle nutrient uptake but that so called 'nutritive' blood
flow is an important determinant. Recent work suggests that bulk limb flow is not only
partitioned between skin, bone and muscle but even within muscle is partitioned between
'nutritive' and 'non-nutritive'. The nutritive route has intimate contact with muscle cells
while the non-nutritive route acts as a vascular shunt and is thought to be, at least in
part, via vessels that nourish fat and connective tissue cells. Nutritive flow may be the
component of flow which is most susceptible to dysfunction5 (e.g. with type 2 diabetes and
obesity) but may also be the most susceptible to improvement by accustomed exercise and
possibly nutraceutical treatment.
The investigators will test the hypotheses: (1) muscle nutritive blood flow is a determinant
of protein balance, with pharmacologically induced vasodilation acutely stimulating muscle
synthesis and reducing breakdown, (2) low nutritive flow in elderly people contributes to
anabolic resistance and can be ameliorated by resistance training or nutraceutical flow
enhancers.
The investigators wish to study 50 healthy volunteer subjects (not NHS patients) as follows:
18-28 y men (10) and 65-75 y men (40) of comparable body mass index (24-28 kg•m2) all of
whom are sedentary and normally undertake no customary resistance training. The
investigators have data suggesting sexual dimorphism of anabolic responses to feeding in
older subjects so will restrict studies to men only. After obtaining written consent, all
subjects will undergo a medical examination, activity questionnaire and DEXA scan. Ten
elderly men will undergo a single acute study. In addition the investigators will study 10
young men under the same conditions. Ten more elderly men will undergo an acute study after
20 weeks of supervised whole-body resistance training, as is current practice at a gym site
in Derby. Ten more elderly men will undergo a single acute study in which they are given, in
addition to the standard acute study protocol 3 drinks of high flavanol cocoa and 3 x 500 mg
of vitamin C. If a positive acute effect of the drinks is observed the final ten elderly men
will undergo an acute study after a week of ingesting 3 high flavanol cocoa + 1000 mg of
vitamin C per day. To optimise details of study conditions the investigators will also study
up to 10 normal healthy volunteers 18-75 y simply with the CEUS contrast agent and
methacholine infusions, without any blood sampling or biopsies.
Subjects fasted overnight will receive primed constant intravenous (antecubital vein)
infusions of stable isotope labelled amino acids for the duration of the study and blood
samples will be taken from an arterial cannula and two femoral venous cannulae at regular
intervals to quantify tracer enrichment and measure glucose uptake and insulin. In the first
phase of the study, subjects' bulk femoral artery blood flow will be measured at 50, 70, 90
and 110 min by Doppler Ultrasound (USS). Nutritive blood flow will be measured in a defined
area of the quadriceps in the control leg by Contrast Enhanced Ultrasound (CEUS) using the
Phillips iU22 at 110 min. This involves a single intravenous administration of SonoVue®
contrast agent. At 120 min the second phase of the study will begin with a dextrose and
mixed amino acid intravenous infusion (antecubital vein) for the remainder of the study.
Methacholine chloride (Provocholine®; Methapharm Inc.) in NaCl (0.9%, prepared by QMC
pharmacy)will be infused (at 2-12 µg/min) into one femoral artery to double femoral artery
flow at 150 min. Bulk femoral artery flow will again be measured (Doppler Ultrasound), this
time in both legs at 170, 190, 210 and 230 min. Nutritive flow will be measured for a second
time, in both legs by CEUS at 230 min. Four muscle biopsies (150-300 mg) of vastus lateralis
will be taken according to the protocol and snap-frozen in liquid nitrogen.
The end points will be i. muscle protein synthesis, ii. muscle protein breakdown, iii. bulk
femoral blood flow and iv. nutritive femoral blood flow in subjects of different ages or
following different exercise or nutraceutical intervention. A power calculation suggests
that this study will need 10 subjects per group to detect (with α of 0.05 and β of 0.85) a
25 % difference between groups in biological variables, results the investigators have been
able to achieve for similar work in the past.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00431691 -
Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.
|
Phase 4 | |
Completed |
NCT00810927 -
Role of Nitrogen Oxide (NO) in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00431392 -
Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions
|
Phase 2 | |
Completed |
NCT00540215 -
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
|
N/A | |
Completed |
NCT02589054 -
Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study
|
N/A | |
Completed |
NCT00707226 -
Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes
|
N/A | |
Completed |
NCT00709449 -
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
|
Phase 2/Phase 3 | |
Terminated |
NCT00708357 -
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
|
Phase 0 | |
Terminated |
NCT00709657 -
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
|
N/A | |
Completed |
NCT00709423 -
Effects of Moxaverine and Placebo on Ocular Blood Flow
|
Phase 2 | |
Completed |
NCT00814008 -
The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
|
Phase 2 | |
Completed |
NCT00708929 -
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?
|
N/A | |
Completed |
NCT00712400 -
Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects
|
N/A | |
Completed |
NCT00312325 -
Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans
|
Phase 4 | |
Withdrawn |
NCT00312390 -
Amblyopia and Neurovascular Coupling in the Retina of Humans
|
N/A | |
Withdrawn |
NCT00406731 -
Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00275730 -
Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers
|
N/A | |
Completed |
NCT00312416 -
Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise
|
Phase 4 | |
Completed |
NCT00712907 -
Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow
|
N/A | |
Withdrawn |
NCT02978560 -
Indocyanine Green Tissue Perfusion Monitoring
|